Mimedx (MDXG) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 50.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.12% |
| Dec 31, 2025 | 59.10% |
| Sep 30, 2025 | 60.00% |
| Jun 30, 2025 | 72.18% |
| Mar 31, 2025 | 119.50% |
| Dec 31, 2024 | 27.34% |
| Jun 30, 2024 | 0.56% |
| Mar 31, 2024 | -20.80% |
| Dec 31, 2023 | 24.34% |
| Jun 30, 2023 | -5.31% |
| Mar 31, 2023 | -19.10% |
| Dec 31, 2022 | -24.27% |
| Sep 30, 2022 | -19.19% |
| Jun 30, 2022 | -14.71% |
| Mar 31, 2022 | -10.70% |
| Dec 31, 2021 | -9.11% |
| Sep 30, 2021 | -17.33% |
| Jun 30, 2021 | 76.36% |
| Mar 31, 2021 | 58.40% |
| Dec 31, 2020 | 38.72% |
| Sep 30, 2020 | 16.44% |
| Jun 30, 2020 | -50.26% |
| Mar 31, 2020 | 88.51% |
| Dec 31, 2019 | 53.09% |
| Dec 31, 2018 | 64.21% |
| Dec 31, 2017 | -9.38% |
| Sep 30, 2017 | 99.16% |
| Jun 30, 2017 | 99.69% |
| Mar 31, 2017 | 104.56% |
| Dec 31, 2016 | 15.28% |
| Sep 30, 2016 | -55.35% |
| Jun 30, 2016 | -38.34% |
| Mar 31, 2016 | -60.93% |
| Dec 31, 2015 | -43.54% |
| Sep 30, 2015 | -13.08% |
| Jun 30, 2015 | -1.64% |
| Mar 31, 2015 | -10.05% |
| Dec 31, 2014 | 5.68% |
| Sep 30, 2014 | 679.51% |
| Jun 30, 2014 | 835.83% |
| Mar 31, 2014 | 651.41% |
| Dec 31, 2013 | 552.62% |
| Sep 30, 2013 | -20.46% |
| Jun 30, 2013 | 57.97% |
| Mar 31, 2013 | 89.49% |
| Dec 31, 2012 | 64.21% |
| Sep 30, 2012 | 1,096.06% |
| Jun 30, 2012 | 64.44% |
| Mar 31, 2012 | 196.05% |
| Dec 31, 2011 | 206.73% |